Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105453 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carmen De Caro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences Department, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Metagenomics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gut microbiota imbalances have a significant role in the pathogenesis of Inflammatory Bowel Disease (IBD) and Non-Alcoholic Fatty Liver Disease (NAFLD). Herein, we compared gut microbial composition in patients diagnosed with either IBD or NAFLD or a combination of both. Seventy-four participants were stratified into four groups: IBD-NAFLD, IBD-only, NAFLD-only patients, and healthy controls (CTRLs). The 16S rRNA was sequenced by Next-Generation Sequencing. Bioinformatics and statistical analysis were performed. Bacterial α-diversity showed a significant lower value when the IBD-only group was compared to the other groups and particularly against the IBD-NAFLD group. β-diversity also showed a significant difference among groups. The higher Bacteroidetes/Firmicutes ratio was found only when comparing IBD groups and CTRLs. Comparing the IBD-only group with the IBD-NAFLD group, a decrease in differential abundance of Subdoligranulum, Parabacteroides, and Fusicatenibacter was found. Comparing the NAFLD-only with the IBD-NAFLD groups, there was a higher abundance of Alistipes, Odoribacter, Sutterella, and Lachnospira. An inverse relationship in the comparison between the IBD-only group and the other groups was shown. For the first time, the singularity of the gut microbial composition in IBD and NAFLD patients has been shown, implying a potential microbial signature mainly influenced by gut inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Sciences Department, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
- Experimental and Clinical Medicine Department, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
- Unit of Gastroenterology and Operative Endoscopy, University Hospital "Renato Dulbecco" of Catanzaro, 88100 Catanzaro, Italy.
- Medical and Surgical Sciences Department, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
ORCID-Profile: Carmen De Caro, Rocco Spagnuolo, Elisa Mazza, Federico Carrabetta, Samantha Maurotti, Francesco Bennardo, Emilio Russo, Amerigo Giudice, Nadia Marascio
Zitieren
APA
De Caro, C., Spagnuolo, R., Quirino, A., Mazza, E., Carrabetta, F., Maurotti, S., Cosco, C., Bennardo, F., Roberti, R., Russo, E., Giudice, A., Pujia, A., Doldo, P., Matera, G., & Marascio, N. (2024). Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105453
Vancouver
De Caro C, Spagnuolo R, Quirino A, Mazza E, Carrabetta F, Maurotti S, et al. Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105453
BibTeX
@article{DeCaro2024,
author = {De Caro, Carmen and Spagnuolo, Rocco and Quirino, Angela and Mazza, Elisa and Carrabetta, Federico and Maurotti, Samantha and Cosco, Cristina and Bennardo, Francesco and Roberti, Roberta and Russo, Emilio and Giudice, Amerigo and Pujia, Arturo and Doldo, Patrizia and Matera, Giovanni and Marascio, Nadia},
title = {Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105453}
}
EUVIMED